Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first) - A prospective multicenter phase IIA study
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 May 2017
At a glance
- Drugs Everolimus (Primary) ; Prednisone (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- Acronyms PredEver first
- 07 May 2017 Planned End Date changed from 1 Jul 2017 to 31 Jan 2018.
- 07 May 2017 Planned primary completion date changed from 1 Jan 2017 to 31 Jan 2017.
- 11 May 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Jan 2017.